Trial Profile
XELODA Special Drug Use Surveillance, XELOX as adjuvant chemotherapy for colon cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2020
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Colon cancer
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 11 Feb 2015 New trial record